Phase 1 Study of CM082 in Patients With wAMD

Summary

This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CM082 tablets in Chinese Patients With wAMD.

Timeline

Start

2015-03

Primary completion

2020-06

Completion

2020-06

Publications

• Gao Y, Lu F, Li X, Dai H, Liu K, Liu X, Sun Z, Xiang J, Ding L, Liang C, Wang Y, Shen Z, Zhang M. Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study. Eye (Lond). 2023 Oct;37(15):3228-3233. doi: 10.1038/s41433-023-02496-x. Epub 2023 Apr 11.

Drugs

Indications